{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:38:03Z","timestamp":1791013083471,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ejmech.2012.08.042","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T01:05:07Z","timestamp":1346979907000},"page":"126-133","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Synthesis and antiviral evaluation of bis(POM) prodrugs of (E)-[4\u2032-phosphono-but-2\u2032-en-1\u2032-yl]purine nucleosides"],"prefix":"10.1016","volume":"57","author":[{"given":"Ugo","family":"Prad\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Montagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Balzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi A.","family":"Agrofoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2012.08.042_bib1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2012.08.042_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A\u00a0novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2012.08.042_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/AAC.37.2.332","article-title":"Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in\u00a0vitro and in\u00a0vivo antiretrovirus activities of (R)-9-(2-Phosphonylme thoxypropyl)-2,6-diaminopurine","volume":"37","author":"Balzarini","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2012.08.042_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2010.02.001","article-title":"Human and viral nucleoside\/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties","volume":"86","author":"Deville-Bonne","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2012.08.042_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.addr.2007.05.013","article-title":"Prodrug strategies to overcome poor water solubility","volume":"59","author":"Stella","year":"2007","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejmech.2012.08.042_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0065-7743(04)39023-8","article-title":"Prodrug strategies in the design of nucleoside and nucleotide antiviral therapeutics","volume":"39","author":"Mackman","year":"2004","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.08.042_bib7","first-page":"373","article-title":"Current prodrug strategies for the delivery of nucleotides into cells","volume":"2","author":"Ariza","year":"2005","journal-title":"Drug Des. Rev."},{"key":"10.1016\/j.ejmech.2012.08.042_bib8","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/jm701260b","article-title":"Prodrugs of phosphates and phosphonates","volume":"51","author":"Hecker","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.08.042_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm1011462","article-title":"Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonate selected as human thymidylate kinase substrates","volume":"54","author":"Topalis","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.08.042_bib10","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1016\/j.tet.2011.05.017","article-title":"Expeditious convergent procedure for the preparation of bis(POC) prodrugs of (E)-4-phosphono-but-2-en-1-yl nucleoside","volume":"67","author":"Montagu","year":"2001","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2012.08.042_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1081\/NCN-100002298","article-title":"Acyclic\/carbocyclic guanosine analogues as anti-herpesvirus agents","volume":"20","author":"De Clercq","year":"2001","journal-title":"Nucleos. Nucleot. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2012.08.042_bib12","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/jm00112a010","article-title":"Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo,[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir","volume":"34","author":"Boryski","year":"1991","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.08.042_bib13","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1016\/j.bmc.2006.07.036","article-title":"Tricyclic etheno analogs of PMEG and PMEDAP: synthesis and biological activity","volume":"14","author":"Ho\u0159ej\u0161\u00ed","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2012.08.042_bib14","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1135\/cccc20011545","article-title":"Synthesis and cytostatic activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, 2,6 diaminopurines and related compounds","volume":"66","author":"Hol\u00fd","year":"2001","journal-title":"Collect. Czechoslov. Chem. Commun."},{"key":"10.1016\/j.ejmech.2012.08.042_bib15","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1128\/AAC.46.11.3356-3361.2002","article-title":"Antivaccinia activities of acyclic phosphonate derivatives in epithelial cells and organotypic cultures","volume":"46","author":"Snoeck","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2012.08.042_bib16","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1002\/ejoc.201101111","article-title":"The shortest strategy for generating phosphonate prodrugs by olefin cross metathesis \u2013 application to acyclonucleoside phosphonates","volume":"36","author":"Prad\u00e8re","year":"2011","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2012.08.042_bib17","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/jm9811256","article-title":"Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base","volume":"42","author":"Hol\u00fd","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2012.08.042_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-1981-29317","article-title":"The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products Mitsunobu","volume":"1","author":"Mitsunobu","year":"1981","journal-title":"Synthesis"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412005338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523412005338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T01:21:45Z","timestamp":1542763305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523412005338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":18,"alternative-id":["S0223523412005338"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2012.08.042","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}